Daniel Hume
CIK: 0001645514
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)1 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About HUME DANIEL
HUME DANIEL (SEC CIK 0001645514) files insider reports with the SEC as Director of TG THERAPEUTICS, INC. (TGTX) and Director of Insight Digital Partners II (DYOR).
Signal8 holds 4 ownership filings by HUME DANIEL (1 Form 3, 3 Form 4), filed between Mar 18, 2025 and Jun 15, 2026. Those filings report 3 transactions, from Mar 17, 2025 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on HUME DANIEL's filings is in MORRISVILLE, NC.
Recent filings by HUME DANIEL
Other insiders filing for TG THERAPEUTICS, INC. (TGTX)
- Charney Laurence N, Director
- Lonial Sagar, Director
- Hoberman Kenneth, Director
- Echelard Yann, Director
- WEISS MICHAEL S, CEO
- Power Sean A, CFO